Sabby Management »

Neximmune shares owned by Sabby Management

Quarter-by-quarter ownership of Neximmune (NEXI) shares owned by Sabby Management from 13F filings

Historical chart of Sabby Management investment in Neximmune

Tip: Access up to 7 years of quarterly data

All positions including Neximmune held by Sabby Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neximmune by Sabby Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $336k 60k 5.61

More positions owned by Sabby Management

Spdr S&p 500 Etf Tr Etf Put Option
Ishares Tr Etf Put Option
Spdr S&p 500 Etf Tr Etf Call Option
Ishares Tr Etf Call Option
Vivani Medical (VANI)
Eltek SHS (ELTK)
Core Scientific Note (Principal)
Redhill Biopharma Ads (RDHL)
Tonix Pharmaceuticals Hldg (TNXP)
Global Mofy Metaverse Ord (GMM)
China Natural Resources SHS (CHNR)
Checkpoint Therapeutics Put Option
Bit Digital SHS Put Option
Recon Technology Cl A (RCON)
Biovie Cl A (BIVI)

View all positions for Sabby Management

Top funds holding Neximmune

Sabby Management
Slate Path Capital
EPIQ Capital Group
Pnc Financial Services
Vanguard Group
Raymond James & Associates
Brian McDonald
Tower Research Capital
Royal Bank of Canada
Bnp Paribas Arbitrage, Snc
Wells Fargo & Company
UBS Group

View all funds holding Neximmune